Session 1 - 15:00 - 15:45
This webinar will provide practical advice to aid delegates understanding of physical deconditioning in their patients with Parkinson’s, how to identify and prevent this, and then look at the treatment options and strategies available to them to address/prevent deconditioning.
Daiga Heisters, Interim Head of Parkinson's Academy, Neurology Academy
Julie Jones, Physiotherapist, Clinical Academic Fellow, and Senior Lecturer, at Robert Gordon University
Dr Richard Davenport, Consultant Neurologist, NHS Lothian
Session 2 - 15:45 - 16:30
Symposium Title: The impact of COVID-19 on Parkinson’s Disease in the short term, and long COVID-19 issues
Join Profile Pharma’s (a subsidiary of Zambon SpA) promotional webinar where research neurologists Dr Katarina Rukavina and Dr Valentina Leta from King’s College London will present an insight into their published and ongoing research on the impact of COVID-19 on Parkinson’s Disease and people living with Parkinson’s Disease.
Dr.med. Katarina Rukavina, Neurologist, King’s Parkinson's Centre Movement Disorders PhD Fellow
Valentina Leta, MD Neurologist, PhD Clinical Research Fellow
This webinar has received sponsorship from Profile Pharma Ltd. The first session in the webinar is designed and delivered by the Parkinson’s Academy and sponsored by Profile Pharma Ltd; the sponsor has had no input into the educational content or organisation of the session. The second session is a satellite symposium that is designed and delivered by Profile Pharma Ltd.